Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sodium-Glucose co Transporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Liver Fibrosis: A Preliminary Retrospective Study

NCT05943899 is registered in ClinicalTrials.gov with Diabetes Foundation, India as lead sponsor.

NCT NCT05943899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05943899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sodium-Glucose co Transporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Liver Fibrosis: A Preliminary Retrospective Study
Lead sponsor
Diabetes Foundation, India
Phase
Observational
Overall status
Completed
Start date
February 1, 2020
Completion date
June 30, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type2diabetes